<DOC>
	<DOCNO>NCT01292733</DOCNO>
	<brief_summary>The main purpose program see whether periodically measure CA-125 ( tumor marker ) level blood undergoing transvaginal ultrasound time effective early detection ovarian cancer .</brief_summary>
	<brief_title>Cancer Screening Program Women High Risk Developing Ovarian Cancer</brief_title>
	<detailed_description>The program offer twice yearly CA-125 blood test annual transvaginal ultrasound monitor woman high risk ovarian cancer . In addition main purpose provide ovarian cancer screening , researcher would also like build repository blood specimen use ovarian breast cancer research offer genetics counsel session help educate woman risk-reducing option .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Ovarian Diseases</mesh_term>
	<criteria>Must meet one follow : The family contain least two ovarian breast cancer subject first second degree relative subject . The subject Ashkenazi Jewish ethnicity one first degree two seconddegree relative breast ovarian cancer , subject Ashkenazi ancestry breast cancer . The subject male relative breast cancer diagnose age . Probability carry BRCA1/2 mutation give family pedigree breast ovarian cancer exceed 20 % ( determined BRCAPRO 95 % posterior probability interval ) . Prior ovarian cancer peritoneal carcinomatosis A first second degree relative BRCA1/2 mutation test negative exactly mutation . The subject ovary . Less 30 year age , unless 2530 BRCA I II mutation confirm Currently pregnant Currently receive adjuvant chemotherapy radiation therapy cancer ( exclude tamoxifen ) . Patients treat local disease may enroll 3 month completion last treatment ( exclude tamoxifen ) . Treatment ( exclude tamoxifen ) prior metastatic malignancy within past five year . Intraperitoneal surgery within last 3 month .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Women increase risk develop ovarian cancer</keyword>
	<keyword>Women diagnose reproductive cancer</keyword>
	<keyword>Women relatives ovarian breast cancer</keyword>
</DOC>